EGF, TGFα, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1447-1452

  Ruck, Anders ^a   Paulie, Staffan ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

AR; Autocrine; Bladder carcinoma; EGF; Epidermal growth factor receptor; HB EGF; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

ACIDIFICATION; ARTICLE; AUTOCRINE EFFECT; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031826935     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Peles E and Yarden Y: Neu and its ligands: From an oncogene to neural factors. BioEssays 15: 815-824, 1993.
2. Elenius K, Paul S, Allison G, Sun J and Klagsbrun M: Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16: 1268-1278, 1997.
3. Graus-Porta D, Beerli RR, Daly JM and Hynes NE: ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling, EMBO J 16: 1647-1655, 1997.
4. Hynes NE and Stern DF: The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165-184, 1994.
5. Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD and Stern DF: The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor and amphiregulin to Neu, ErbB-3 and ErhB-4. J Bio Chem 271: 20047-20052, 1996.
6. Beerli RR and Hynes NE: Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 271: 6071 -6067, 1996.
7. Tzahar E, Lewkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Cnang D, Liu N, Yayon A, Wen D and Yarden Y: ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/Heregulin isoforms. J Biol Chem 269: 25226-25233, 1994.
8. Weiss FU, Daub H and Ullrich A:Novel mechanisms of RTK signal generation. Curr Opin Genenetic Development 7: 80-86, 1997.
9. Messing EM: Clinical implications of the expression of epidermal growth factor receptor in human transitional cell carcinoma. Cancer Res 50: 2530-2537, 1990.
10. Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE, Harris A L and Waterfield MD: Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 56: 533-537, 1987.
11. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JRD and Harris AL: Epidermal-growth-factor receptors in human bladder cancer: Comparison of invasive and superficial tumours. Lancet 1: 366-368, 1985.
12. Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR and Harris AL: Epidermal growth factor receptor in human bladder cancer: A comparison of immunohistochemical and ligand binding. J Urol 141: 517-521, 1989.
13. Smith K, Fennelly JA, Neal DE, Hall RR and Harris LA: Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. Cancer Res 49: 5810-5815, 1989.
14. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Dykoski D, Harvey J and Niehans GA: Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Amer J Clin Pathol 101: 166-176, 1994.
15. Mellon K, Wrigth C, Kelly P, Horne W and Neal DE: Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 153:919-925, 1995.
16. Neal DE, Sharples L, Smith K, Fennelly JA, Hall RR and Harris AL: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65: 1619-1625, 1990.
17. Coombs LM, Oliver S, Sweeney E and Knowles, M: Immunocytochemical localization of c-erbB2 protein in transitional cell carcinoma of the urinary bladder. J Path 169: 35-42, 1993.
18. Gorgoulis V, Tsatsanis C, Ozanne B and Spandidos DA: Detection of epidermal growth factor receptor and c erbB-2 gene amplification in the transitional cell bladder carcinoma using the differential PCR technique. Int J Oncology 4: 1191-1197, 1994.
19. Wright C, Mellon K, Johnson P, Lane DP, Harris AL, Home CHW and Neal DE: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63: 967-970, 1991.
20. Zhau HE, Zhang X, von Eschenbach AC, Scorsone K, Babaian RJ, Ro JY and Hung M-C: amplification and expression of the c-erbB-2/neu proto-oncogene in human bladder cancer. Mol Carcinogenesis 3: 254-257, 1990.
21. Sauter G, Moore MD, Carroll P, Kerschmann R, Chew K, Mihatsch M-J, Gudat F and Waldman F: Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53; 2199-2203, 1993.
22. Lönn U, Lönn S, Friberg S, Nilsson, Silversward C and Stenkvist B: Prognostic value of amplification of c-erbB-2 in bladder cancer. Clin Cancer Res 1: 1189-1194, 1995.
23. Rajkumar T, Stamp GWH, Pandha HS, Waxman J, and Gulllick WJ: Expression of the type 1 tyrosine kinase growth factor receptor, C-erbB-2 and c-erbB-3 in bladder cancer. J Path 179: 381-385, 1996.
24. Press MF, Cordon-Cardo C and Slamon D J :Expression of the HER-2/neu proto-oncogene in human adult and fetal tissues: Oncogene 5: 953-962, 1990.
25. Prigent SA, Lemoine NR, Huges CM, Plowman GD, Selden C and Gullick WJ: Expression of the c-erbB-3 protrin in normal human adult and fetal tissues. Oncogene 7: 1273-1278, 1992.
26. Ruck A and Paulie S: The epidermal growth factor receptor is involved in autocrine growth of human bladder carcinoma cell lines. Anticancer Res. 17: 1925-1932, 1997.
27. Gleave ME, Hsieh J-H, Wu H-C, Hong S-J, Zhau HE, Guthrei PD and Chung LWK: Epidermal growth factor receptor-mediated autocrine and paractine stimulation of human bladder transitional cell carcinoma. Cancer Res 53: 5300-5307, 1993.
28. Ruck A, Jakobson E, Bjorkman S and Paulie S: Adaptation of human bladder carcinoma cell lines to serum-free growth. Evidence for autocrine growth stimulation. Anticancer Res 14: 55-60, 1994.
29. Hansson Y, Jakobson E, Örtlund J, Paulie S and Perlman P: A rapid method for detecting of cellular proliferation using carboxyfluorescein. J Immunol Meth 100: 162-267, 1987.
30. Imanishi K, Yamaguchi M, Suzuki M, Honda S, Yanarihara N and Abe K: Production of transforning growth factor-α in human tumor cell lines. Br J Cancer 59: 761 -765, 1989.
31. Derynck R, Goeddel, DV, Ullrich A, Gutterman JU, Williams RD, BringmanTS and Berger WH:Syntesis of messenger RNAs for transforming growth factor α and ß and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987.
32. Mellon JK, Cook S, Chambers P and Neal DE: Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor: Br J Cancer 75: 654-658, 1996.
33. Hirst MA and Pitchford S: Use of a single assay system to assess functional coupling of a variety of receptors. J NIH Res 5: 69, 1993.
34. Dunbar CE, Browder TM, Abrams JS and Nienhuis AW: COOH-terminal-modified interleukin-3 is retained intracellulary and stimulates autocrine growth. Science 245: 1493-1496, 1989.
35. Keating MT and Williams LT: Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239: 914-916, 1988.
36. Adam R, Drummond DD, Solic N. Holt SJ, Sharma RP, Chamberlin SG and Davies DE: Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. Biochim Biophys Acta 7266: 83-90, 1995.
37. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M and Atala A: Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 99: 1028-1036, 1997.
38. Baskin LS, Sutherland RS, Thomson AA, Nguyen H-T, Morgan MD, Hayward SW, Hom YK, Disandro M and Cunha GR: Growth factors in bladder wound healing. J Urology 157: 2388-2395, 1997.
39. Messing EM and Reznikoff CA: Normal and malignant human Urothelium: In vitro effects of epidermal growth factor. Cancer Res 47: 2230-2235, 1987.
40. Dubeau L and Jones PA: Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res 47: 2107-2112, 1987.
41. Wille JJ, Park J and Elgavish A: Effects of growth factors, hormones, bacterial lipopolysaccharids, and liptechoic acids on the clonal growth of normal ureteral epithelial cells in serum-free culture. J Cell physiology 150: 52-58, 1992.
42. Cilento BG, Freeman MR, Schneck FX, Retrik AB and Atala A: Phenotypic and cytogenetic charaterization of human bladder urothelia expanded in vitro. J Urol 152: 665-670, 1994.
43. Detmar M, Brown LF, Claffey KP, Yeo K-T, Kocher O, Jackman RW, Berse B and Dvorak HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its ligand in psoriasis. J Exp Med 180: 1141-1146, 1994.